Zivo Bioscience, Inc. announced plans to create ZIVOLife LLC (ZIVOLife), a newly formed wholly-owned subsidiary, to streamline the Company's corporate structure, better capitalize on the global agtech market opportunity and accelerate progress toward generating revenue from the Company's proprietary algae biomass. Under the new corporate structure, ZIVO Bioscience will grant ZIVOLife an exclusive worldwide limited license to the Company's intellectual property related to proprietary algal cultures, for the production and supply of whole algae biomass products from ZIVO Bioscience's proprietary algal cultures for limited application for human consumption and skincare, excluding all animal and pharmaceutical (human and animal) applications. ZIVOLife will, in turn, enter into long-term strategic sales, marketing and distribution agreements.

Upon the signing of a definitive license agreement, ZIVO Bioscience will be eligible to receive royalty payments from ZIVOLife for the licensed use of the Company's proprietary algal cultures and farming technology used in production, and will grant ZIVOLife rights to the ZIVO name. The new structure allows ZIVOLife to raise capital from third parties to advance and expand its business. The Company believes these transactions should create substantial value for ZIVO Bioscience stakeholders by accelerating the path to revenue, sharpening its strategic focus on biotechnology products and expanding growth opportunities.

To the extent ZIVOLife attracts additional third-party investment in the future, ZIVO Bioscience's interest in the operations of ZIVOLife may be diluted. With separate business structures, ZIVO Bioscience and ZIVOLife will be better positioned to: Focus on their core strategic priorities, with distinct capital structures and financial targets that best support their markets, opportunities and success; Execute with increased agility and operational flexibility, deploying capital and resources in a manner consistent with those strategic priorities; Optimize each business for profitable growth; Attract and retain talent that's best suited for distinct businesses and geographies; and Provide a clear investment thesis and transparency to attract investors that are most appropriate for each company. With responsibility for production and supply, ZIVOLife holds the right to sublicense algal culture and farming technology to contracted growers, but will maintain control of global inventory to be re-sold and distributed through its distribution agreements such as the one with ZWorldwide.

This structure enables ZIVOLife to pursue global market opportunities by commercializing products in geographies that are conducive to the proprietary algae technology.